Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma. Roschewski M, Dunleavy K, Abramson JS, Powell BL, et al. J Clin Oncol 2020 May 26:JCO2000303. doi: 10.1200/JCO.20.00303.

Read + Share

Amedeo Smart

Independent Medical Education

Roschewski M, Dunleavy K, Abramson JS, Powell BL, et al. Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma. J Clin Oncol 2020 May 26:JCO2000303. doi: 10.1200/JCO.20.00303.
PMID: 32453640